This article has been cited by
1First-line antituberculosis drug, pyrazinamide, itspharmaceutically relevant cocrystals and a salt
Kashyap Kumar Sarmah,Trishna Rajbongshi,Sourav Bhowmick,Ranjit Thakuria
Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials.2017;73(5)1007
[DOI]
2First-line antituberculosis drug, pyrazinamide, itspharmaceutically relevant cocrystals and a salt
Arjun Poudel,Lisa M. Nissen
Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials.2018;73(5)263
[DOI]
3Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis
Patrick McMullan,Vamadevan S. Ajay,Ravi Srinivas,Sandeep Bhalla,Dorairaj Prabhakaran,Amitava Banerjee
Global Health Action.2018;11(1)1434935
[DOI]
4The Dilemma of Medical Reimbursement Policy in Rural China: Spatial Variability between Reimbursement Region and Medical Catchment Area
Yongqing Dong,Liping Fu,Ronghui Tan,Liman Ding
International Journal of Environmental Research and Public Health.2019;16(16)2867
[DOI]
5Essential medicines for emergency care in Africa
Morgan C Broccoli,Jennifer L Pigoga,Mulinda Nyirenda,Lee Wallis,Emilie J Calvello Hynes
Emergency Medicine Journal.2018;35(7)412
[DOI]
6Essential medicines for emergency care in Africa
M.C. Broccoli,J.L. Pigoga,M. Nyirenda,L.A. Wallis,E.J. Calvello Hynes
African Journal of Emergency Medicine.2018;8(3)110
[DOI]
7Indian healthcare value chain status quo not a sustainable solution
Gopalakrishnan Narayanamurthy,Roger Moser,Yves Sutter,G. Shainesh
Journal of Asia Business Studies.2017;11(4)481
[DOI]
8Highly Sensitive Immunochromatographic Identification of Tetracycline Antibiotics in Milk
N. A. Taranova,A. S. Kruhlik,E. A. Zvereva,V. V. Shmanai,I. I. Vashkevich,D. A. Semyonov,S. A. Eremin,A. V. Zherdev,B. B. Dzantiev
International Journal of Analytical Chemistry.2015;2015(4)1
[DOI]
  Feedback 
  Subscribe